Orbia Advance Corporation SAB de CV
Orbia Advance Corporation SAB de CV is a chemicals company that produces commodity chemicals and generates revenue primarily through the sale of chemical products.
Business. Orbia Advance Corporation SAB de CV is a Mexican company operating in the commodity chemicals industry within the broader chemicals sector. The firm generates revenue through the sale of commodity-grade chemicals and specialty branded formulations. It is headquartered in Mexico and is primarily listed on the Bolsa Mexicana de Valores under the ticker ORBIA.MX. Specific details regarding operating segments and geographic revenue mix are not available.
Analyst recommendations
14 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Orbia Advance Corporation SAB de CV is a Mexican company operating in the commodity chemicals industry within the broader chemicals sector. The firm generates revenue through the sale of commodity-grade chemicals and specialty branded formulations. It is headquartered in Mexico and is primarily listed on the Bolsa Mexicana de Valores under the ticker ORBIA.MX. Specific details regarding operating segments and geographic revenue mix are not available.
Orbia's capital structure is characterized by a high debt-to-equity ratio of 2.67, indicating significant leverage. The company's liquidity position is moderate, with a current ratio of 1.52, but its free cash flow is negative at -115 million USD, which may constrain its ability to fund operations without external financing. The company's return on equity is -21.41%, and its return on assets is -4.13%, both of which are below typical performance metrics for the industry.
In terms of profitability, Orbia's net income is negative at -457 million USD, and its operating income is 370 million USD, which is lower than the industry median for commodity chemicals. The company's gross profit of 1.626 billion USD suggests some level of cost control, but the overall profitability is weak. The company's operating cash flow is 840 million USD, which is a positive sign, but it is not sufficient to cover capital expenditures of 405 million USD.
Orbia's revenue is concentrated in the chemicals segment, with no disclosed geographic breakdown. The company's exposure to a single business line may increase its vulnerability to market fluctuations in the chemicals industry. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. However, the company's capital expenditures suggest ongoing investment in its operations.
The company faces several risk factors, including a high debt-to-equity ratio and negative free cash flow, which could lead to liquidity constraints. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag. There are no recent events or filings that significantly impact the company's risk profile.
Analyst estimates for Orbia are mixed, with a mean price target of 26.33 USD and a median price target of 25.00 USD. The mean recommendation is 2.50, indicating a slight bias towards a hold or buy rating. There is one strong-buy recommendation, six buy recommendations, and six hold recommendations.
- Orbia has a high debt-to-equity ratio of 2.67, indicating significant leverage.
- The company's net income is negative at -457 million USD, and its operating income is 370 million USD, which is lower than the industry median for commodity chemicals.
- Orbia's liquidity position is moderate, with a current ratio of 1.52, but its free cash flow is negative at -115 million USD.
- The company's return on equity is -21.41%, and its return on assets is -4.13%, both of which are below typical performance metrics for the industry.
- Analyst estimates for Orbia are mixed, with a mean price target of 26.33 USD and a median price target of 25.00 USD.
- "margin_outlook_rationale": "The company's gross profit margin is 21.33%, but the net margin is negative at -6.00%, indicating significant cost pressures and operational inefficiencies.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,03 |
| Revenue | —no estimate | —no estimate | 8,1B USD |
| Operating income | —no estimate | —no estimate | 569,0M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Orbia Advance Corporation SAB de CV Market data — financials · 2026-05-28
- Orbia Advance Corporation SAB de CV Market data — analyst estimates · 2026-05-28
- Orbia Advance Corporation SAB de CV Market data — ESG · 2026-05-28